Medical Marijuana, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Medical Marijuana, Inc. (OTCMKTS:MJNA), founded in 2003 and headquartered in San Diego, California, operates as a holding company focused on the development, manufacturing, marketing, and distribution of hemp-derived cannabidiol (CBD) products for health, beauty, and wellness applications; its core offerings include Triple Lab Tested CBD oil concentrates, tinctures, capsules, topicals, skincare items, dietary supplements, plant-based non-GMO pet products, and RSHO oil for treating various illnesses, distributed via e-commerce, direct sales, retail, and network marketing through subsidiaries such as HempMeds and Kannaway, with operations spanning the United States, Mexico, Paraguay, and international markets including plans for expansion into Brazil, Spain, Korea, and the Philippines. The company pioneered the world's first legal CBD supply, introduced government-subsidized botanical cannabis-based products in Mexico and Paraguay, and maintains involvement in cannabis drug development, industry support services, and new market development for medical cannabis. Recent developments include the 2024 acquisition agreement for Kannaway, a hemp products startup valued at up to $243 million, and the completion by its Kannaway division of acquiring KZ1 Network Marketing Company to bolster direct-selling capabilities.
Medical Marijuana (OTCMKTS:MJNA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why
Medical Marijuana (OTCMKTS:MJNA) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?
Medical Marijuana (OTCMKTS:MJNA) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next?
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
AGL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that agilon health, inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
10 Penny Stocks You Can Have for Less Than a Dime
Medical Marijuana's Subsidiary Kannaway Reveals Record Revenue Month For South Africa And Japan Divisions
Medical Marijuana Inc's Stock Down On Q3 Results And Slight Revenue Decline
Medical Marijuana, Inc. Subsidiary Kannaway® Appoints Internationally-Acclaimed Direct Sales Leader Peter J.E. Verdegem as Vice President
Medical Marijuana, Inc. Subsidiary Kannaway® Appoints Direct Sales Veteran Lennon Ledbetter as Vice President of Sales
Medical Marijuana, Inc. Celebrates Largest Revenue Month for Japan Division of Subsidiary Kannaway® and Manufacturing Subsidiary
Medical Marijuana, Inc. Subsidiary Kannaway Launches in Hong Kong
Medical Marijuana, Inc. CEO Featured in Industry Era Magazine Highlighting International Expansion Efforts
Medical Marijuana Inc. Shares Slightly Up On Announcing Increase In Q2 2021 Revenue And Net Income
Medical Marijuana, Inc. Reports Increased Revenue and Net Income QoQ in 2021 Second Quarter Financial and Operational Results
Medical Marijuana, Inc. International Subsidiaries Achieve Best Revenue Month Ever in July 2021
HempMeds' Latin American Operations Hit Record Revenue Month In June, Up By 84% From May
Medical Marijuana, Inc. Subsidiary HempMeds® Latin American Operations Achieves Best Revenue Month Ever in June 2021
Medical Marijuana, Inc. Subsidiary HempMeds® Welcomes UFC Champion Raoni Barcelos as Brand Spokesperson